UBS OCONNOR LLC - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 71 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$1,365,191
+8.0%
585,919
+10.4%
0.03%
-15.0%
Q2 2023$1,263,587
-9.3%
530,919
-29.9%
0.04%
-7.0%
Q1 2023$1,392,895
-99.9%
757,008
+29.5%
0.04%
+79.2%
Q3 2022$1,251,000,000
-24.3%
584,406
+0.0%
0.02%0.0%
Q2 2022$1,653,000,000584,2460.02%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 3,530,657$23,126,0001.85%
TFG Asset Management GP Ltd 2,500,000$16,375,0001.00%
Nantahala Capital Management 2,936,791$19,236,0000.61%
MYDA Advisors LLC 171,953$1,126,0000.32%
SABBY MANAGEMENT, LLC 300,000$1,965,0000.27%
Regency Capital Management Inc.\DE 57,000$373,0000.26%
Ikarian Capital, LLC 544,819$3,568,0000.25%
Eversept Partners, LP 398,074$2,607,3850.18%
Henry James International Management Inc. 54,047$354,0000.11%
Alphabet Inc. 698,262$4,574,0000.11%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders